Clinical trial
Continuous Glucose Monitoring Systems in People With Type 2 Diabetes Not Treated With Insulin - the Association With Metabolic Control of Diabetes and Markers of Early Vascular Changes
NCT07919236 is registered in ClinicalTrials.gov with Medical University of Bialystok as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Continuous Glucose Monitoring Systems in People With Type 2 Diabetes Not Treated With Insulin - the Association With Metabolic Control of Diabetes and Markers of Early Vascular Changes
- Lead sponsor
- Medical University of Bialystok
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 30, 2026
- Completion date
- May 31, 2028
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes
Arms
As registered; 2 arms.
-
Continuous glucose monitoring
Dexcom One+ continuous glucose monitoring system
-
Self-monitoring of blood glucose
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Change in time in range
Observed change in time in range (70-180 mg/dl) from baseline to week 12 in the group using CGM system compared to the group using SMBG.
Lead sponsor's other trials
Medical University of Bialystok, most recent start first.
+66 more trials See the organization page
Similar trials
Same condition (Diabetes Mellitus, Type 2) and phase, most recent start first.
+3,730 more trials See the condition page